Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
GSK256066 has been demonstrated to have exceptional potency in vitro and in vivo and is being clinically investigated as a treatment for chronic obstructive pulmonary disease
Ondansetron HCl anhydrous is a competitive serotonin type 3 receptor antagonist
4-difluorophenyl)amino]-5-[(2R)-2
2020:2054293
BMS453 Catalog No.:M13146-2 GSK256066 has been demonstrated toBMS453 (BMS 189453), a synthetic retinoid, is a RAR agonist and a RAR RAR antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGF. Product information CAS Number: 166977 43 1 Molecular Weight: 380. 48 Formula: C27H24O2 Synonym: BMS 189453 Chemical Name: 4 [(E) 2 (5,5 dimethyl 8 phenyl 5,6 dihydronaphthalen 2 yl)ethenyl]benzoic acid Smiles: CC1(C)CC=C(C2=CC( C=C C3C=CC(=CC=3)C(O)=O)=CC=C12)C1C=CC=CC=1 InChiKey:
US$ 129.06
US$ 88.73
US$ 46.70